Acrux Limited (ACR.AX)
AUD 0.02
(-4.17%)
AUD 0.02
(-4.17%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 | 147 Thousand AUD | 0.0% |
| 2023 | - AUD | -100.0% |
| 2022 | 1.00 AUD | 0.0% |
| 2021 | - AUD | 0.0% |
| 2020 | - AUD | 0.0% |
| 2019 | - AUD | -100.0% |
| 2018 | 1.00 AUD | 0.0% |
| 2017 | - AUD | 0.0% |
| 2016 | - AUD | -100.0% |
| 2015 | 1.00 AUD | 0.0% |
| 2014 | - AUD | -100.0% |
| 2013 | 1.00 AUD | 0.0% |
| 2012 | - AUD | 0.0% |
| 2011 | - AUD | 0.0% |
| 2010 | - AUD | 0.0% |
| 2009 | - AUD | 0.0% |
| 2008 | - AUD | 0.0% |
| 2007 | - AUD | 0.0% |
| 2006 | - AUD | 0.0% |
| 2005 | - AUD | -100.0% |
| 2004 | 107.96 Thousand AUD | -20.21% |
| 2003 | 135.3 Thousand AUD | 0.0% |
| 2002 | - AUD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 FY | - AUD | 0.0% |
| 2024 Q4 | 147 Thousand AUD | 0.0% |
| 2024 Q2 | - AUD | 0.0% |
| 2023 FY | - AUD | -100.0% |
| 2023 Q4 | - AUD | 0.0% |
| 2023 Q2 | 1.00 AUD | 0.0% |
| 2022 Q4 | 1.00 AUD | 0.0% |
| 2022 FY | 1.00 AUD | 0.0% |
| 2022 Q2 | 1.00 AUD | 0.0% |
| 2021 Q4 | - AUD | 0.0% |
| 2021 FY | - AUD | 0.0% |
| 2021 Q2 | 1.00 AUD | 0.0% |
| 2020 FY | - AUD | 0.0% |
| 2020 Q2 | 1.00 AUD | 0.0% |
| 2020 Q4 | - AUD | 0.0% |
| 2019 Q2 | - AUD | 0.0% |
| 2019 Q4 | - AUD | 0.0% |
| 2019 FY | - AUD | -100.0% |
| 2018 FY | 1.00 AUD | 0.0% |
| 2018 Q4 | 1.00 AUD | 0.0% |
| 2018 Q2 | - AUD | 0.0% |
| 2017 Q2 | - AUD | 0.0% |
| 2017 FY | - AUD | 0.0% |
| 2017 Q4 | - AUD | 0.0% |
| 2016 Q4 | - AUD | 0.0% |
| 2016 FY | - AUD | -100.0% |
| 2016 Q2 | - AUD | 0.0% |
| 2015 FY | 1.00 AUD | 0.0% |
| 2015 Q4 | 1.00 AUD | 0.0% |
| 2015 Q2 | - AUD | 0.0% |
| 2014 FY | - AUD | -100.0% |
| 2014 Q4 | - AUD | 0.0% |
| 2014 Q2 | - AUD | 0.0% |
| 2013 Q4 | 1.00 AUD | 0.0% |
| 2013 FY | 1.00 AUD | 0.0% |
| 2013 Q2 | 1.00 AUD | 0.0% |
| 2012 FY | - AUD | 0.0% |
| 2012 Q4 | - AUD | 0.0% |
| 2011 Q4 | - AUD | 0.0% |
| 2011 FY | - AUD | 0.0% |
| 2010 Q4 | - AUD | 0.0% |
| 2010 FY | - AUD | 0.0% |
| 2009 Q4 | - AUD | 0.0% |
| 2009 FY | - AUD | 0.0% |
| 2008 FY | - AUD | 0.0% |
| 2008 Q4 | - AUD | 0.0% |
| 2007 FY | - AUD | 0.0% |
| 2007 Q4 | - AUD | 0.0% |
| 2006 Q4 | - AUD | 0.0% |
| 2006 FY | - AUD | 0.0% |
| 2005 FY | - AUD | -100.0% |
| 2005 Q4 | - AUD | 0.0% |
| 2004 FY | 107.96 Thousand AUD | -20.21% |
| 2004 Q4 | 107.96 Thousand AUD | 0.0% |
| 2003 FY | 135.3 Thousand AUD | 0.0% |
| 2002 FY | - AUD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| AdAlta Limited | -1.67 Million AUD | 108.752% |
| Biome Australia Limited | 1.88 Million AUD | 92.216% |
| Radiopharm Theranostics Limited | -987.41 Thousand AUD | 114.887% |
| Biotron Limited | - AUD | -Infinity% |
| Alterity Therapeutics Limited | 1.00 AUD | -14699900.0% |
| Botanix Pharmaceuticals Limited | 1.2 Million AUD | 87.845% |
| BTC Health Limited | - AUD | -Infinity% |
| Chimeric Therapeutics Limited | - AUD | -Infinity% |
| CSL Limited | 8.93 Billion AUD | 99.998% |
| Clarity Pharmaceuticals Ltd | - AUD | -Infinity% |
| Clinuvel Pharmaceuticals Limited | 10.62 Million AUD | 98.617% |
| Immutep Limited | 2.00 AUD | -7349900.0% |
| Memphasys Limited | 164.76 Thousand AUD | 10.78% |
| Neuren Pharmaceuticals Limited | - AUD | -Infinity% |
| Noxopharm Limited | -2.35 Million AUD | 106.231% |
| Prescient Therapeutics Limited | - AUD | -Infinity% |
| Race Oncology Limited | 16.4 Thousand AUD | -796.287% |
| Starpharma Holdings Limited | 2.4 Million AUD | 93.895% |
| Tissue Repair Ltd | 214.72 Thousand AUD | 31.539% |
| EZZ Life Science Holdings Limited | 1.4 Million AUD | 89.509% |
| Anatara Lifesciences Ltd | -671.09 Thousand AUD | 121.905% |
| Bio-Gene Technology Limited | - AUD | -Infinity% |
| Zelira Therapeutics Limited | 1.25 Million AUD | 88.262% |
| Patrys Limited | - AUD | -Infinity% |
| Orthocell Limited | 1.17 Million AUD | 87.507% |
| Imugene Limited | - AUD | -Infinity% |
| PYC Therapeutics Limited | -17.99 Million AUD | 100.817% |
| Proteomics International Laboratories Limited | - AUD | -Infinity% |
| Cynata Therapeutics Limited | 108.2 Thousand AUD | -35.854% |
| Arovella Therapeutics Limited | - AUD | -Infinity% |
| Nanollose Limited | - AUD | -Infinity% |
| Invex Therapeutics Ltd | -94.98 Thousand AUD | 254.765% |
| NeuroScientific Biopharmaceuticals Limited | - AUD | -Infinity% |
| Amplia Therapeutics Limited | - AUD | -Infinity% |
| Island Pharmaceuticals Limited | -877.24 Thousand AUD | 116.757% |
| Nyrada Inc. | - AUD | -Infinity% |
| Telix Pharmaceuticals Limited | 17.31 Million AUD | 99.151% |
| Dimerix Limited | - AUD | -Infinity% |
| PharmAust Limited | - AUD | -Infinity% |
| Hexima Limited | - AUD | -Infinity% |
| AnteoTech Limited | 221.85 Thousand AUD | 33.741% |
| Paradigm Biopharmaceuticals Limited | - AUD | -Infinity% |
| Recce Pharmaceuticals Ltd | - AUD | -Infinity% |
| Avecho Biotechnology Limited | 97.11 Thousand AUD | -51.364% |
| Actinogen Medical Limited | 108.82 Thousand AUD | -35.074% |
| Immuron Limited | 1.58 Million AUD | 90.723% |
| Argenica Therapeutics Limited | - AUD | -Infinity% |